Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

KFDA Clearance for StoneChecker Software

20 Jan 2020 07:00

RNS Number : 2389A
IQ-AI Limited
20 January 2020
 

IQ-AI Ltd

("IQ-AI" or the "Company")

 

IQ-AI Announce Korean FDA Clearance to Market for StoneChecker Software, and GMP certification for Imaging Biometrics, and the appointment of Dr Balaji Ganeshan as consultant

 

IQ-AI has received notification that the Korean FDA (KFDA) has cleared StoneChecker Software for marketing in the Republic of Korea, a key market for high-tech medical imaging hardware and software. In addition, Imaging Biometrics (IB) has received GMP certification.

 

Trevor Brown, Chief Executive of IQ-AI commented, "We are delighted that StoneChecker Software has received KFDA approval for marketing in the Republic of Korea, our Korean distributor's marketing plans can now be fully implemented. It also gives me great pleasure to welcome back Dr Balaji Ganeshan to the team. Dr Ganeshan, an exceptionally innovative medical imaging entrepreneur and scientist, has invaluable expertise and ideas in a number of key technologies relevant to the Company. He will be working as a consultant for IB."

 

Dr Ganeshan, who was previously a director of StoneChecker Software, holds the position of Senior Research Associate at the Institute of Nuclear Medicine at University College London and is a prolific academic scientist in the area of medical image analysis. 

 

Dr. Balaji Ganeshan commented, "I very much look forward to working alongside Trevor Brown again, and also the team at IB, on all the technologies that IQ-AI have access to."

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

-ENDS-

 

For further information, please contact:

IQ-AI Limited

Trevor Brown/Michael Schmainda

Tel: 020 7469 0930

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

About IQ-AI Ltd 

IQ-AI, Ltd, the parent company of StoneChecker® and Imaging Biometrics®, is focused on advanced and state of the art medical software and services. Imaging Biometrics develops and provides visualization and analytical solutions that enable clinicians to better diagnose and treat diseases with greater confidence. Through close collaboration with researchers and clinicians, sophisticated advancements are translated into platform-independent software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB's advanced visualization software seamlessly integrates into routine workflows. Please visit www.imagingbiometrics.com for further information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRSFFFAUESSEEF
Date   Source Headline
1st May 20127:00 amRNSCompletion of Sale
30th Apr 20126:36 pmRNSFinal Results- Replacement
30th Apr 20127:00 amRNSAnnual Results Announcement
27th Apr 201211:47 amRNSResult of EGM
11th Apr 20124:24 pmRNSPosting of Circular and Notices of two EGMs
5th Apr 201211:34 amRNSRe. Flowers Direct
30th Mar 20127:54 amRNSPurchase of Assets
30th Mar 20127:00 amRNSProposed disposals
20th Mar 20123:00 pmRNSMerger Update
21st Feb 20127:59 amRNSProposed sale of the Gifts Division
24th Jan 20127:00 amRNSTrading Statement
20th Dec 201112:07 pmRNSApproaches for Certain of the Company's Assets
7th Dec 20117:00 amRNSCompletion of disposals
30th Nov 201110:58 amRNSResult of EGM
15th Nov 20117:00 amRNSPosting of Circular to Shareholders
3rd Nov 20117:00 amRNSInterim Management Statement & Directorate Change
26th Sep 20117:00 amRNSProposed sale of certain non-core property assets
23rd Sep 20117:00 amRNSTrading Statement
29th Jul 20117:00 amRNSHalf Yearly Report
21st Apr 20112:42 pmRNSResult of AGM
21st Apr 20117:00 amRNSContract win with Debenhams
13th Apr 20117:00 amRNSTrading Statement
10th Mar 201110:42 amRNSProposed Dividend - Clarification
10th Mar 20117:00 amRNSFinal Results
20th Jan 20111:43 pmRNSAcquisition
14th Jan 20117:00 amRNSTrading Statement
17th Nov 20101:36 pmRNSAdditional Directorship for John Henwood
26th Oct 20107:00 amRNSInterim Management Statement
26th Oct 20107:00 amRNSInterim Management Statement
4th Oct 201012:25 pmRNSBlocklisting Interim Review
19th Aug 20107:00 amRNSCompletion of Acquisition of Garden Centre Online
11th Aug 20107:00 amRNSHalf Yearly Report
26th Jul 20101:56 pmRNSNotice of Results
24th May 201012:28 pmRNSAcquisition
12th May 201010:19 amRNSResult of AGM
12th May 20107:00 amRNSTrading Update
21st Apr 20101:32 pmRNSDirector/PDMR Shareholding
21st Apr 20107:00 amRNSDirector/PDMR Shareholding
20th Apr 201010:27 amRNSAdjournment of AGM
20th Apr 20109:09 amRNSReplacement Interim Management Statement
20th Apr 20107:00 amRNSInterim Management Statement
8th Apr 201011:12 amRNSDirector Update
1st Apr 201011:08 amRNSBlocklisting Interim Review
11th Mar 20107:00 amRNSFinal Results
13th Jan 20107:00 amRNSTrading Statement
19th Oct 20097:00 amRNSInterim Management Statement
15th Oct 20097:00 amRNSPlacing of Shares
1st Oct 20097:00 amRNSStrategic changes at Flying Flowers
30th Sep 20099:32 amRNSBlocklisting Interim Review
8th Sep 20093:08 pmRNSIssue of shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.